VK2735 for Weight Management Phase 2
Public ClinicalTrials.gov record NCT06068946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 13-week Study of VK2735 for Weight Management in Subjects Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition
Study identification
- NCT ID
- NCT06068946
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Viking Therapeutics, Inc.
- Industry
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Interventions
- VK2735 Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2023
- Primary completion
- Feb 26, 2024
- Completion
- Apr 1, 2024
- Last update posted
- Feb 11, 2025
2023 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Viking Clinical Site #119 | Birmingham | Alabama | 35235 | — |
| Viking Clinical Site #114 | Long Beach | California | 90815 | — |
| Viking Clinical Site #110 | Los Angeles | California | 90057 | — |
| Viking Clinical Site #113 | Tustin | California | 92780 | — |
| Viking Clinical Site #116 | Clearwater | Florida | 33756 | — |
| Viking Clinical Site #106 | Clearwater | Florida | 33761 | — |
| Viking Clinical Site #112 | Jacksonville | Florida | 32216 | — |
| Viking Clinical Site #105 | Ocoee | Florida | 34761 | — |
| Viking Clinical Site #107 | Port Orange | Florida | 32127 | — |
| Viking Clinical Site #104 | Indianapolis | Indiana | 46260 | — |
| Viking Clinical Site #103 | Louisville | Kentucky | 40213 | — |
| Viking Clinical Site #109 | Marrero | Louisiana | 70072 | — |
| Viking Clinical Site #102 | Kansas City | Missouri | 64131 | — |
| Viking Clinical Site #111 | Butte | Montana | 59701 | — |
| Viking Clinical Site #108 | Knoxville | Tennessee | 37920 | — |
| Viking Clinical Site #101 | Austin | Texas | 78705 | — |
| Viking Clinical Site #118 | Austin | Texas | 78731 | — |
| Viking Clinical Site #100 | Phoenix | Texas | 85210 | — |
| Viking Clinical Site #115 | San Antonio | Texas | 78229 | — |
| Viking Clinical Site #117 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06068946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2025 · Synced Jul 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06068946 live on ClinicalTrials.gov.